• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丙酮处理的百日咳疫苗——一种高效且更安全的新型百日咳疫苗。

Acetone-treated pertussis vaccine--a potent and safer new pertussis vaccine.

作者信息

Saran G

出版信息

J Biol Stand. 1985 Oct;13(4):315-20. doi: 10.1016/s0092-1157(85)80045-7.

DOI:10.1016/s0092-1157(85)80045-7
PMID:4055808
Abstract

A vaccine was prepared from the growth of Bordetella pertussis by repeated treatment with acetone. The vaccine has been designated as acetone-treated pertussis vaccine (ATPV). A total of ten batches of ATPV were prepared, five each from B. pertussis strains 134 and 509. These strains are routinely employed at this Institute for the production of conventional whole-cell pertussis vaccine (WCPV) for blending in diphtheria-pertussis-tetanus vaccine. The mouse protective and histamine sensitizing activities of ATPV and WCPV were compared. The ATPV showed 1.5- to 2-fold higher potency than the WCPV. The histamine sensitizing activity of ATPV was much reduced compared with that of the WCPV. No appreciable difference was observed in the results of a mouse weight-gain tests between the ATPV and WCPV. The details of the preparation of ATPV have been described. Because of higher potency and reduced histamine sensitizing activity, the ATPV may prove more acceptable in immunization programmes against pertussis, even in countries where WCPV is unpopular due to its suspected reactogenicity.

摘要

通过用丙酮反复处理百日咳博德特氏菌的培养物制备了一种疫苗。该疫苗被指定为丙酮处理的百日咳疫苗(ATPV)。共制备了十批ATPV,其中五批来自百日咳博德特氏菌菌株134,五批来自菌株509。该研究所通常使用这些菌株生产用于白喉-百日咳-破伤风疫苗混合的常规全细胞百日咳疫苗(WCPV)。比较了ATPV和WCPV的小鼠保护活性和组胺致敏活性。ATPV的效力比WCPV高1.5至2倍。与WCPV相比,ATPV的组胺致敏活性大大降低。在ATPV和WCPV之间的小鼠体重增加试验结果中未观察到明显差异。已经描述了ATPV的制备细节。由于效力更高且组胺致敏活性降低,即使在因怀疑有反应原性而WCPV不受欢迎的国家,ATPV在百日咳免疫计划中可能也会被证明更易接受。

相似文献

1
Acetone-treated pertussis vaccine--a potent and safer new pertussis vaccine.丙酮处理的百日咳疫苗——一种高效且更安全的新型百日咳疫苗。
J Biol Stand. 1985 Oct;13(4):315-20. doi: 10.1016/s0092-1157(85)80045-7.
2
Comparative biological activities of whole cell pertussis vaccine and a new acellular preparation.全细胞百日咳疫苗与一种新型无细胞制剂的比较生物学活性
Vaccine. 1985 Mar;3(1):23-6. doi: 10.1016/0264-410x(85)90005-2.
3
Glutaraldehyde inactivated pertussis vaccine: a less histamine sensitizing vaccine.
J Biol Stand. 1987 Apr;15(2):159-64. doi: 10.1016/0092-1157(87)90038-2.
4
Pertussis vaccines: present status.
Adv Biotechnol Processes. 1990;13:169-99.
5
Comparative toxicity, protective, histamine sensitizing and leucocytosis promoting activities in mice of Bordetella pertussis culture fluid, bacterial cells and cell extracts.百日咳博德特氏菌培养液、细菌细胞及细胞提取物对小鼠的比较毒性、保护作用、组胺致敏及促白细胞增多活性
Med Microbiol Immunol. 1984;173(4):225-32. doi: 10.1007/BF02122114.
6
The effects of different inactivating agents on the potency, toxicity and stability of pertussis vaccine.不同灭活剂对百日咳疫苗效力、毒性及稳定性的影响。
J Biol Stand. 1987 Jan;15(1):87-98. doi: 10.1016/0092-1157(87)90020-5.
7
[Vaccine from the cell fragments of Bordetella pertussis. I. Protective, sensitizing properties and morphological characteristics of the vaccine].[百日咳博德特氏菌细胞碎片疫苗。I. 疫苗的保护、致敏特性及形态特征]
Zh Mikrobiol Epidemiol Immunobiol. 1976 Nov(11):103-8.
8
Development of a pertussis component vaccine in Japan.日本百日咳组分疫苗的研发。
Lancet. 1984 Jan 21;1(8369):122-6. doi: 10.1016/s0140-6736(84)90061-8.
9
Collaborative study for the standardisation of the histamine sensitizing test in mice and the CHO cell-based assay for the residual toxicity testing of acellular pertussis vaccines.小鼠组胺致敏试验标准化及基于CHO细胞的无细胞百日咳疫苗残留毒性检测协作研究。
Pharmeur Bio Sci Notes. 2010 Apr;2010(1):51-63.
10
[The safety and protective properties of a new cell-free pertussis vaccine in animal trials].[一种新型无细胞百日咳疫苗在动物试验中的安全性和保护特性]
Zh Mikrobiol Epidemiol Immunobiol. 1994 Jan-Feb(1):40-5.